Np mrd loader

Record Information
Version2.0
Created at2022-09-11 14:08:50 UTC
Updated at2022-09-11 14:08:51 UTC
NP-MRD IDNP0315489
Secondary Accession NumbersNone
Natural Product Identification
Common Name1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
DescriptionCeftazidime, also known as CAZ or ceptaz, belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof. Ceftazidime is a drug which is used for the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: Lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis). Ceftazidime is a strong basic compound (based on its pKa). 1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium is found in Apis cerana. 1-{[(6r,7r)-2-carboxy-7-{[(2z)-2-[(1-carboxylato-1-methylethoxy)imino]-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium was first documented in 1992 (PMID: 1384868). A third-generation cephalosporin antibiotic bearing pyridinium-1-ylmethyl and {imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton (PMID: 11252323) (PMID: 11284241) (PMID: 11591698) (PMID: 11605815) (PMID: 11815759) (PMID: 12048030).
Structure
Thumb
Synonyms
ValueSource
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateChEBI
CAZChEBI
CeftazidimaChEBI
Ceftazidime anhydrousChEBI
CeftazidimumChEBI
CeptazKegg
FortazKegg
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidGenerator
Pentahydrate, ceftazidimeHMDB
FortumHMDB
Anhydrous, ceftazidimeHMDB
Ceftazidime pentahydrateHMDB
TazidimeHMDB
Chemical FormulaC22H22N6O7S2
Average Mass546.5760 Da
Monoisotopic Mass546.09914 Da
IUPAC Name1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
Traditional Nameceftazidime
CAS Registry NumberNot Available
SMILES
[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1
InChI Identifier
InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1
InChI KeyORFOPKXBNMVMKC-DWVKKRMSSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Apis ceranaLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as cephalosporins. Cephalosporins are compounds containing a 1,2-thiazine fused to a 2-azetidinone to for a oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid moiety or a derivative thereof.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassLactams
Sub ClassBeta lactams
Direct ParentCephalosporins
Alternative Parents
Substituents
  • Cephalosporin
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid or derivatives
  • 2,4-disubstituted 1,3-thiazole
  • Meta-thiazine
  • Dicarboxylic acid or derivatives
  • 1,3-thiazol-2-amine
  • Pyridine
  • Pyridinium
  • Azole
  • Heteroaromatic compound
  • Tertiary carboxylic acid amide
  • Thiazole
  • Amino acid or derivatives
  • Azetidine
  • Carboxamide group
  • Carboxylic acid salt
  • Amino acid
  • Secondary carboxylic acid amide
  • Thioether
  • Hemithioaminal
  • Dialkylthioether
  • Azacycle
  • Carboxylic acid derivative
  • Carboxylic acid
  • Primary amine
  • Organic nitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Organic salt
  • Organonitrogen compound
  • Organic zwitterion
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-1.2ALOGPS
logP-4.1ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)2.77ChemAxon
pKa (Strongest Basic)4.26ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count10ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area191.22 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity143.88 m³·mol⁻¹ChemAxon
Polarizability51.06 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDHMDB0014582
DrugBank IDDB00438
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4587145
KEGG Compound IDC06889
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCeftazidime
METLIN IDNot Available
PubChem Compound5481173
PDB IDNot Available
ChEBI ID3508
Good Scents IDNot Available
References
General References
  1. Shimizu T, Souma S, Nagakura N, Masuzawa T, Iwamoto Y, Yanagihara Y: Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity. Int Arch Allergy Immunol. 1992;98(4):392-7. doi: 10.1159/000236216. [PubMed:1384868 ]
  2. Marumo K, Takeda A, Nakamura Y, Nakaya K: Detection of OXA-4 beta-lactamase in Pseudomonas aeruginosa isolates by genetic methods. J Antimicrob Chemother. 1999 Feb;43(2):187-93. doi: 10.1093/jac/43.2.187. [PubMed:11252323 ]
  3. Orrett FA, Shurland SM: Neonatal sepsis and mortality in a regional hospital in Trinidad: aetiology and risk factors. Ann Trop Paediatr. 2001 Mar;21(1):20-5. doi: 10.1080/02724930020028867. [PubMed:11284241 ]
  4. Zhang Z, Yu Y, Musser JM, Palzkill T: Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase. J Biol Chem. 2001 Dec 7;276(49):46568-74. doi: 10.1074/jbc.M102757200. Epub 2001 Oct 8. [PubMed:11591698 ]
  5. Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW: Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect. 2001 Sep;34(3):215-9. [PubMed:11605815 ]
  6. Bruckner LB, Korones DN, Karnauchow T, Hardy DJ, Gigliotti F: High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr. 2002 Jan;140(1):20-6. doi: 10.1067/mpd.2002.118886. [PubMed:11815759 ]
  7. Di Martino P, Gagniere H, Berry H, Bret L: Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients. Microbes Infect. 2002 May;4(6):613-20. doi: 10.1016/s1286-4579(02)01579-4. [PubMed:12048030 ]
  8. Astal Z, El-Manama A, Sharif FA: Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip. J Chemother. 2002 Jun;14(3):259-64. doi: 10.1179/joc.2002.14.3.259. [PubMed:12120880 ]
  9. Barekzi NA, Felts AG, Poelstra KA, Slunt JB, Grainger DW: Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections. Pharm Res. 2002 Dec;19(12):1801-7. doi: 10.1023/a:1021481122011. [PubMed:12523657 ]
  10. White NJ: Melioidosis. Lancet. 2003 May 17;361(9370):1715-22. doi: 10.1016/s0140-6736(03)13374-0. [PubMed:12767750 ]
  11. Guerrero C, Cesteros R, Miranda A, Menasalvas A, Blazquez R, Segovia M: [Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Murcia, Spain]. Rev Esp Quimioter. 2003 Dec;16(4):444-9. [PubMed:14961139 ]
  12. Bret L, Di Martino P: Effect of ceftazidime, amikacin and ciprofloxacin on biofilm formation by some enterobacterial clinical isolates. Chemotherapy. 2004 Nov;50(5):255-9. doi: 10.1159/000081947. Epub 2004 Nov 3. [PubMed:15528892 ]
  13. Araki H, Ogake N, Tsuneda R, Minami S, Watanabe Y, Tamai I, Tsuji A: Muscle distribution of antimicrobial agents after a single intravenous administration to rats. Drug Metab Pharmacokinet. 2002;17(3):237-44. doi: 10.2133/dmpk.17.237. [PubMed:15618675 ]
  14. Perez-Capilla T, Baquero MR, Gomez-Gomez JM, Ionel A, Martin S, Blazquez J: SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol. 2005 Feb;187(4):1515-8. doi: 10.1128/JB.187.4.1515-1518.2005. [PubMed:15687217 ]
  15. de Jong CE, Jonsson N, Field H, Smith C, Crichton EG, Phillips N, Johnston SD: Collection, seminal characteristics and chilled storage of spermatozoa from three species of free-range flying fox (Pteropus spp.). Theriogenology. 2005 Sep 15;64(5):1072-89. doi: 10.1016/j.theriogenology.2005.02.016. [PubMed:15913752 ]
  16. LOTUS database [Link]